share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director SMITH JAMES C

SEC announcement ·  Apr 2 01:36
Summary by Futu AI
James C. Smith, a reporting person for Pfizer Inc [PFE], executed a transaction involving Pfizer shares on March 28, 2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The number of shares held by Smith after the transaction was also not provided.
James C. Smith, a reporting person for Pfizer Inc [PFE], executed a transaction involving Pfizer shares on March 28, 2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The number of shares held by Smith after the transaction was also not provided.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.